Sarma-Com Vita FX Women's Daily 60 caps
Multivitamin for women from Sarma-Com, 60 capsules.
Esaurito
Product highlights
- Vitamin C300 mg in the formula
- Magnesium200 mg in the formula
- Standardised to 98% polyphenolsAs stated by the manufacturer
- Chelated mineralsBisglycinate form
Impossibile caricare la disponibilità di ritiro
- Original products
- Free delivery over €199* See delivery zones
- Customer support Message us with any questions
About this product
About Sarma-Com Vita FX Women's Daily 60 caps
Sarma-Com Vita FX Women's Daily 60 caps is a multivitamin for women from Sarma-Com with 10 named ingredients, including vitamin A, vitamin C and vitamin E. Every amount is stated under Ingredients & Composition.
Who is it for? Adults looking for a multivitamin for women. Not intended for children. If you are pregnant, breastfeeding or taking medication, ask your doctor first.
Ingredients & Composition
- Vitamin A
- 10,000 IU
- Vitamin C
- 300 mg
- Vitamin E
- 400 IU
- Vitamin K
- 50 mcg
- Folate
- 400 mcg
- Boron
- 1 mg
- Calcium
- 100 mg
- Iodide
- 225 mg
- Magnesium (from magnesium oxide, chelate, stearate)
- 200 mg
- Copper (from copper citrate)
- 1 mg
The manufacturer's text states 225 mg of iodide, which appears to be a unit error (a typical amount is 225 µg). Check the product label before use. Amounts as stated by the manufacturer.
Manufacturer's Directions
Take 1 serving (2 capsules) daily.
Do not exceed the stated amount; always follow the product label.
Safety & Product Information
Sold as a food supplement. No health claims are made for this product.
Always read the product label before use.
Additional Product Information
- Product
- Sarma-Com Vita FX Women's Daily 60 caps
- Product type
- Multivitamin for women
- Form
- Capsules
- Pack
- 60 capsules
- Category
- Food supplement
- Brand
- Sarma-Com
- SKU
- GC-SCO-VITAFXW-60C
- Delivery
- Shipping and delivery zones
Composition, stated amounts, directions and safety information are in the sections above. The product label is the authoritative source.
